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Background
Maternal steroids modulate various functions in the
developing brain. Tamoxifen (TAM) treatment, as an
estrogen antagonist, induced cell death in the rat develop-
ing hippocampus. Estrogen has a variety of physiological
effects in the nervous system, including regulation of cog-
nitive functions, learning, aging, angiogenesis and neuro-
genesis as well as neuroprotective effects.
Aim
In the present study, we demonstrated the effects of TAM
as an estrogen antagonist on nitric oxide synthase activity
in the rat developing hippocampus pyramidal neurons.
Materials and methods
The present description is based on twelve adult rats. The
animals were divided randomly into control, experimen-
tal and sham groups. In each, we have full term embryo
(E22), 1 day neonate (P1), one week neonate (P7) and
three weeks neonate (P21). In experimental groups ani-
mals at full term received four doses of the (250 μg/kg in
propylene glycol i.p. twice a day for a total of four doses).
The hippocampus was removed 6 hours after the last
injection. Animals at the same gestational age were used
as sham and controls. Controls received only propylene
glycol. The hippocampus was dissected out and stored in
fixative and sucrose. Cryostat sections were thaw-
mounted on gelatin slides. The sections were incubated
for NADPH-diaphorase histochemistry by light micros-
copy.
Results
We found that in the earliest stage of development the cel-
lular density is low and there was a gradual increase in cel-
lular thickness, with maximum thickness observed after
third weeks. The short half-life of tamoxifen can change
E22, P1 and P7. The effect of treatment without tamoxifen,
due to existence of estrogen, is characterized by strong
NADPH-diaphorase activity that showed NOS activity.
With treatment with tamoxifen, in the early stages, we
found significant decreases in NADPH-diaphorase reactiv-
ity following estrogen receptor blockade. Furthermore, we
demonstrated a decreased activity of NOS in the CA1 hip-
pocampal region and reduced neuronal cell numbers. The
decreased activity of NOS and reduced hippocampal cell
numbers were observed in E22 and one day neonate and
one week neonate.
Conclusion
Evidence so far suggests that this phenomenon may be the
result of the short half-life of tamoxifen. These findings
indicate that estrogen and selective estrogen modulators
can influence nitric oxide-mediated growth and develop-
ment in pyramidal cells.
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